One of the most notable accomplishments of the first Trump Administration was its willingness to take on the status quo of ...

The department said in a news release that it would waive age limits for new applicants so “even more patriots will qualify ...

Lupin has reported a strong Q1 FY26 with over 50% profit growth and improved margins. Robust U.S. sales—driven by new launches and FDA approvals—along with steady India growth, have fuelled the ...

- Robert Foster will serve as Acting General Counsel at HHS, maintaining his role as FDA Chief Counsel for Food, Research, ...

Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...

T he U.S. Department of Health and Human Services (HHS) said on Tuesday that it will start winding down mRNA vaccine development efforts under a federal health agency focused on developing medical ...

The National Museum of African American History and Culture and the National Museum of American History are holders of some ...

A wave of public alarm over counterfeit and dangerous foreign-made prescription drugs, particularly from China, has reached new heights, according to a recent ...

The Trump administration cancelled about $500 million for research into mRNA vaccines. The move slows progress in using the technology to prevent a future pandemic or treat disease, experts say.

Sarepta Therapeutics (SRPT) stock in focus as report says company hired a Trump-linked lobbying firm after deaths linked to ...

The Trump administration is terminating biodefense research funding for mRNA projects, raising concerns about the nation’s ability to fight future pandemics.

A coalition of states and the District of Columbia, led by New York Attorney General Letitia James, sued the Trump ...